| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 78,078 | 01 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | 01 Mar 2025 | 1 | $0 | 4 | Chief Medical Officer | 04 Mar 2025, 17:13 |
| ACRV | Acrivon Therapeutics, Inc. | 11 Jan 2024 | 1 | $0 | 4 | Chief Medical Officer | 16 Jan 2024, 16:45 |
| ACRV | Acrivon Therapeutics, Inc. | 02 Jan 2024 | 0 | $0 | 3 | Chief Medical Officer | 12 Jan 2024, 16:46 |